ATE251666T1 - Impfstoffe gegen bakterien, die zur blutvergiftung führen - Google Patents

Impfstoffe gegen bakterien, die zur blutvergiftung führen

Info

Publication number
ATE251666T1
ATE251666T1 AT90400734T AT90400734T ATE251666T1 AT E251666 T1 ATE251666 T1 AT E251666T1 AT 90400734 T AT90400734 T AT 90400734T AT 90400734 T AT90400734 T AT 90400734T AT E251666 T1 ATE251666 T1 AT E251666T1
Authority
AT
Austria
Prior art keywords
bacteria
lead
receptors
vaccines against
against bacteria
Prior art date
Application number
AT90400734T
Other languages
English (en)
Inventor
Jean-Christophe Audonnet
Patrick Bruneau
Original Assignee
Merial Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9379871&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE251666(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merial Sas filed Critical Merial Sas
Application granted granted Critical
Publication of ATE251666T1 publication Critical patent/ATE251666T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT90400734T 1989-03-20 1990-03-19 Impfstoffe gegen bakterien, die zur blutvergiftung führen ATE251666T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8903626A FR2644346B1 (fr) 1989-03-20 1989-03-20 Vaccins contre les bacteries septicemiques, preparations d'antigenes de bacteries septicemiques, nouvelles bacteries et vecteurs pour la preparation de ces antigenes ou vaccins

Publications (1)

Publication Number Publication Date
ATE251666T1 true ATE251666T1 (de) 2003-10-15

Family

ID=9379871

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90400734T ATE251666T1 (de) 1989-03-20 1990-03-19 Impfstoffe gegen bakterien, die zur blutvergiftung führen

Country Status (8)

Country Link
EP (1) EP0389347B1 (de)
JP (1) JPH03143388A (de)
AT (1) ATE251666T1 (de)
AU (1) AU5415390A (de)
CA (1) CA2029906A1 (de)
DE (1) DE69034107T2 (de)
FR (1) FR2644346B1 (de)
WO (1) WO1990011349A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
DK0563288T3 (da) * 1990-12-19 1999-09-27 Pfizer Immunopotentiering af vacciner, navnlig svinepleuropneumoniavacciner
GB9112310D0 (en) * 1991-06-07 1991-07-24 United Kingdom Government Fish vaccine
FR2683147B1 (fr) * 1991-10-30 1995-06-23 Maingault Philippe Systeme vehicule de principe actif permettant l'administration voie orale chez les poissons et crustaces.
US5554507A (en) * 1992-07-30 1996-09-10 American Cyanamid Company Bacillus subtilis siderophore genes
EP0659086B1 (de) * 1992-09-04 1998-11-11 The University of Saskatchewan Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien
US5830479A (en) * 1994-02-09 1998-11-03 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
AU1915995A (en) 1994-02-09 1995-08-29 Willmar Poultry Company, Inc. Active immunization using a siderophore receptor protein
US6682754B2 (en) 1999-11-24 2004-01-27 Willmar Poultry Company, Inc. Ovo delivery of an immunogen containing implant
PT1353689E (pt) 2001-01-03 2006-08-31 Epitopix Llc Composicoes imunizantes e metodos de utilizacao
US8119147B2 (en) 2003-09-19 2012-02-21 Epitopix, Llc Compositions produced using enteric pathogens and methods of use
US8729013B2 (en) 2004-08-26 2014-05-20 The University Of Western Ontario Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus
WO2010123845A2 (en) 2009-04-21 2010-10-28 University Of Florida Research Foundation, Inc. Siderophore conjugate immunogenic compositions and vaccines
EP2561063B1 (de) 2010-04-23 2017-01-04 Intervet International B.V. Haemophilus parasuis-bakterien vom serotyp 5 und impfstoff mit diesen bakterien
MX2018000395A (es) 2015-07-10 2018-05-23 Epitopix Llc Proteinas y composiciones inmunizantes que contienen proteinas de klebsiella y metodos de uso.
US10166280B2 (en) 2016-06-08 2019-01-01 Epitopix, Llc Polypeptides and immunizing compositions containing Bacillus polypeptides and methods of use

Also Published As

Publication number Publication date
FR2644346B1 (fr) 1994-05-13
JPH03143388A (ja) 1991-06-18
CA2029906A1 (en) 1990-09-21
DE69034107T2 (de) 2004-07-22
WO1990011349A1 (fr) 1990-10-04
EP0389347A1 (de) 1990-09-26
AU5415390A (en) 1990-10-22
FR2644346A1 (fr) 1990-09-21
DE69034107D1 (de) 2003-11-13
EP0389347B1 (de) 2003-10-08

Similar Documents

Publication Publication Date Title
ATE251666T1 (de) Impfstoffe gegen bakterien, die zur blutvergiftung führen
ATE127694T1 (de) Lebende impfstoffe.
ATE191567T1 (de) Bestimmung von nukleären matrixproteinen in flüssigkeiten
EP0419502A4 (en) Method of detecting bacteria in urine
Smyth Echinococcus granulosus and E. multilocularis: in vitro culture of the strobilar stages from protoscoleces
DE3175677D1 (en) Polysaccharide antigen from streptococcus and vaccines
DE50000243D1 (de) Verwendung von antikörpern zur vakzinierung gegen krebs
DE3889581T2 (de) Monoklonale Antikörper gegen spezifische antigene Regionen des humanen Immundefizienzvirus und Methoden zur Verwendung.
DE3686158T2 (de) Impfstoff gegen mastitis.
DE3681940D1 (de) Reagenz zur bestimmung durch haemagglutination von antikoerpern gegen bakterien-toxine, verfahren zu ihrer herstellung und verwendung.
KR840002238A (ko) 피부용보습제의 제조법
DE3888887D1 (de) Monoklonale Antikörper gegen E7-Protein des Humanen Papillomvirus Typ 16, Verfahren zu ihrer Herstellung sowie ihre Verwendung.
ES2052883T3 (es) Cultivo de celulas de riñon de cerdo y su uso en la produccion de vacunas.
ATE21484T1 (de) An menschliche fibroblastenzellen adaptierte hepatitis-a-viren.
DE3854096D1 (de) Verfahren zur Isolierung von Basalmembranproteinen aus menschlichen und tierischen Geweben.
DE3781421D1 (de) Verfahren zum nachweis von einer infektion oder entzuendung des harnbezueglichen tractus.
SE8205247L (sv) Fiskvacciner
ATE207119T1 (de) Die herstellung von menschlichen, monoklonalen antikörpern, die gegen das oberflächenantigen von hepatitis b aktiv sind
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
FI885025A (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
DK439086D0 (da) Fremgangsmaader til anvendelse af cellelinier, der mangler humane klasseii histokompatibilitetsantigener
AU7377296A (en) Method for treating hepatitis virus infection
Nicolas et al. An Attempt of Oral Way of Vaccination for Ovine Salmonellosis Due to Salmonella abortus ovis, With a Living and Virulent Strain. Note 3: Is the Oral Tract a Possible Way of Vaccination Against Ovine Salmonellosis?.
ATE99333T1 (de) Immunogen und seine verwendung zur gewinnung von antikoerpern gegen haemoglobin a1c.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties